Mika Skeppholm

The Changing Landscape for Stroke Prevention in AF

Menno V. Huisman, Kenneth J. Rothman, Miney Paquette et al. · Journal of the American College of Cardiology · 2017 · 276 citations · Full text

Benefit of Anticoagulation Unlikely in Patients With Atrial Fibrillation and a CHA2DS2-VASc Score of 1

Leif Friberg, Mika Skeppholm, Andreas Terént · Journal of the American College of Cardiology · 2015 · 204 citations

Thrombosis, Cardiovascular Disease, Anticoagulation Unlikely +10

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt et al. · Circulation · 2022 · 142 citations · Full text

Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma

Jovan P. Antović, Mika Skeppholm, Jaak Eintrei et al. · European Journal of Clinical Pharmacology · 2013 · 107 citations

Laboratory Hematology, Coagulation Assays, Medicine +11

Clinical evaluation of laboratory methods to monitor apixaban treatment in patients with atrial fibrillation

Mika Skeppholm, Fadiea Al-Aieshy, Maria Berndtsson et al. · Thrombosis Research · 2015 · 72 citations

Thrombosis, Therapeutic Drug Monitoring, Cardiovascular Disease +12